title: A genetic screen for modifiers of E2F in Drosophila melanogaster.
abstract: The activity of the E2F transcription factor is regulated in part by pRB, the protein product of the retinoblastoma tumor suppressor gene. Studies of tumor cells show that the p16(ink4a)/cdk4/cyclin D/pRB pathway is mutated in most forms of cancer, suggesting that the deregulation of E2F, and hence the cell cycle, is a common event in tumorigenesis. Extragenic mutations that enhance or suppress E2F activity are likely to alter cell-cycle control and may play a role in tumorigenesis. We used an E2F overexpression phenotype in the Drosophila eye to screen for modifiers of E2F activity. Coexpression of dE2F and its heterodimeric partner dDP in the fly eye induces S phases and cell death. We isolated 33 enhancer mutations of this phenotype by EMS and X-ray mutagenesis and by screening a deficiency library collection. The majority of these mutations sorted into six complementation groups, five of which have been identified as alleles of brahma (brm), moira (mor) osa, pointed (pnt), and polycephalon (poc). osa, brm, and mor encode proteins with homology to SWI1, SWI2, and SWI3, respectively, suggesting that the activity of a SWI/SNF chromatin-remodeling complex has an important impact on E2F-dependent phenotypes. Mutations in poc also suppress phenotypes caused by p21(CIP1) expression, indicating an important role for polycephalon in cell-cycle control.
authors.affiliation: Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts 02129, USA.
authors.forename: K
authors.initials: K
authors.lastname: Staehling-Hampton
authors.forename: P J
authors.initials: PJ
authors.lastname: Ciampa
authors.forename: A
authors.initials: A
authors.lastname: Brook
authors.forename: N
authors.initials: N
authors.lastname: Dyson
mesh_terms: D000818:Animals; D002352:Carrier Proteins; D002453:Cell Cycle; D018797:Cell Cycle Proteins; D016923:Cell Death; D004268:DNA-Binding Proteins; D019281:Dimerization; D029721:Drosophila Proteins; D004331:Drosophila melanogaster / Q000033:anatomy & histology / Q000196:embryology / Q000235:genetics* / Q000254:growth & development; D050684:E2F Transcription Factors; D005123:Eye / Q000254:growth & development / Q000378:metabolism / Q000648:ultrastructure; D005799:Genes, Dominant / Q000235:genetics; D017344:Genes, Insect; D018816:Genes, cdc / Q000235:genetics / Q000502:physiology; D005816:Genetic Complementation Test; D019476:Insect Proteins / Q000235:genetics / Q000502:physiology; D008855:Microscopy, Electron, Scanning; D009154:Mutation; D010641:Phenotype; D016160:Retinoblastoma Protein; D056465:Retinoblastoma-Binding Protein 1; D017386:Sequence Homology, Amino Acid; D013489:Suppression, Genetic / Q000235:genetics; D015534:Trans-Activators; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism*
chemical_list: D002352:Carrier Proteins; D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; C088053:Dp transcription factor, Drosophila; D029721:Drosophila Proteins; D050684:E2F Transcription Factors; D019476:Insect Proteins; C099965:Rbf protein, Drosophila; D016160:Retinoblastoma Protein; D056465:Retinoblastoma-Binding Protein 1; D015534:Trans-Activators; D014157:Transcription Factors